Evidence of adherence to allergen-specific immunotherapy.
about
Sublingual immunotherapy: World Allergy Organization position paper 2013 update.Protection against the allergic airway inflammation depends on the modulation of spleen dendritic cell function and induction of regulatory T cells in mice.Development of a questionnaire to assess patient satisfaction with allergen-specific immunotherapy in adults: item generation, item reduction, and preliminary validation.The effect of a new communication template on anticipated willingness to initiate or resume allergen immunotherapy: an internet-based patient surveyGuideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical AssoReduced work/academic performance and quality of life in patients with allergic rhinitis and impact of allergen immunotherapy.Sublingual versus subcutaneous immunotherapy: patient adherence at a large German allergy center.Novel immunotherapeutic approaches for allergy and asthma.Adherence to pharmacological treatment and specific immunotherapy in allergic rhinitis.Balancing efficacy against safety in sublingual immunotherapy with inhalant allergens: what is the best approach?Dropouts in sublingual allergen immunotherapy trials - a systematic review.Allergen immunotherapy: routes, safety, efficacy, and mode of action.Allergen specific sublingual immunotherapy in children with asthma and allergic rhinitis.Can Serum-Specific IgE/Total IgE Ratio Predict Clinical Response to Allergen-Specific Immunotherapy in Children Monosensitized to House Dust Mite?Physician's recommendation and explanation is important in the initiation and maintenance of allergen immunotherapy.Adherence to sublingual immunotherapy in preschool children.Cost-effectiveness of grass pollen subcutaneous immunotherapy (SCIT) compared to sublingual immunotherapy (SLIT) and symptomatic treatment in Austria, Spain, and Switzerland.[Sublingual immunotherapy. Where are we now?].Sublingual grass allergen specific immunotherapy: a retrospective study of clinical outcome and discontinuation.
P2860
Q30440195-6F34F814-0DE4-4F1E-A2D5-AD082670CA91Q33816173-3A403896-DD62-4658-B9E2-A2ED973E220CQ35018998-F5EE0799-9295-4BC4-B424-F093AAE45CDCQ35645654-6B34704D-BEE2-41CE-B986-61E46A264860Q35777126-CF5349EF-B77C-4C71-8212-ABC53DAB3B8FQ37169911-3C937D44-F5C0-47CA-AD23-390BC3C89AE5Q37573127-E7DE5D77-0E65-41F1-9B32-BD490B3B56E4Q37728000-2124985B-3665-491F-8DBE-D931F925281CQ38070806-18F60871-5CA1-45DD-A0E1-1C8DC4655113Q38149941-5976F186-2C50-458F-AE11-CDBE11431728Q38199748-E5F4E4C6-871E-4FEF-86E3-D08C7B576675Q38912244-E6024DCF-EDE6-4EE0-9C96-66FC7EE628F5Q39649421-3E9042FB-DD0D-4991-A3F3-D771AD61D9B4Q41856240-2E790D2B-B432-4DA4-94C9-AD42A3E00D85Q42019552-441BCDDB-25E7-4EB2-B53D-1FB72AA0EF4AQ43502504-E8BDA7AA-BA66-4201-A2E9-5E8D6656C85AQ47570768-F4E29C8F-60D0-40C0-848D-A031F4C633F8Q52895483-6A27E72C-1BF6-4DE9-8C84-F57846B923A2Q55278036-FC0DF310-284C-492E-B287-68584A07C81C
P2860
Evidence of adherence to allergen-specific immunotherapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Evidence of adherence to allergen-specific immunotherapy.
@en
Evidence of adherence to allergen-specific immunotherapy.
@nl
type
label
Evidence of adherence to allergen-specific immunotherapy.
@en
Evidence of adherence to allergen-specific immunotherapy.
@nl
prefLabel
Evidence of adherence to allergen-specific immunotherapy.
@en
Evidence of adherence to allergen-specific immunotherapy.
@nl
P2093
P50
P1476
Evidence of adherence to allergen-specific immunotherapy.
@en
P2093
Carlo Lombardi
Gianenrico Senna
Moises Calderon
P304
P356
10.1097/ACI.0B013E328332B8DF
P577
2009-12-01T00:00:00Z